Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Agorastos

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 11, 2009
Prevalence and distribution of high-risk human papillomavirus in GreeceTheodoros Agorastos, Alexandros F Lambropoulos, Alexandros Sotiriadis, et al.
Archives of Gynecology and Obstetrics|January 30, 2015
Erratum to: Distinct demographic factors influence the acceptance of vaccination against HPVTheodoros Agorastos, Kimon Chatzistamatiou, Menelaos Zafrakas, et al.
Frontiers in Oncology|June 11, 2025
Strategies to accelerate cervical cancer elimination in Greece: a modeling studyCody Palmer, Anastasios Skroumpelos, Ugne Sabale, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 14, 2005
Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions?Theodoros Agorastos, Dimosthenis Miliaras, Alexandros F Lambropoulos, et al.
Molecular Human Reproduction|March 5, 2009
OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemnessSpyros I Papamichos, Vassiliki Kotoula, Basil C Tarlatzis, et al.
BMC Cancer|December 1, 2016
Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control studyEvangelia Pavlidou, Alexandros Daponte, Raquel Egea, et al.
Virology Journal|July 25, 2019
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytologyAleksandra Pesic, Amrei Krings, Matthias Hempel, et al.
Plos One|March 21, 2015
Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytologyTheodoros Agorastos, Kimon Chatzistamatiou, Taxiarchis Katsamagkas, et al.
Gynecologic Oncology|July 2, 2021
Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samplesKimon Chatzistamatiou, Athena Tsertanidou, Theodoros Moysiadis, et al.
Frontiers in Microbiology|December 15, 2023
High risk HPV-positive women cervicovaginal microbial profiles in a Greek cohort: a retrospective analysis of the GRECOSELF studyElectra Sofou, Glykeria Gkoliou, Nikolaos Pechlivanis, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 11, 2009
Prevalence and distribution of high-risk human papillomavirus in GreeceTheodoros Agorastos, Alexandros F Lambropoulos, Alexandros Sotiriadis, et al.
Archives of Gynecology and Obstetrics|January 30, 2015
Erratum to: Distinct demographic factors influence the acceptance of vaccination against HPVTheodoros Agorastos, Kimon Chatzistamatiou, Menelaos Zafrakas, et al.
Frontiers in Oncology|June 11, 2025
Strategies to accelerate cervical cancer elimination in Greece: a modeling studyCody Palmer, Anastasios Skroumpelos, Ugne Sabale, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 14, 2005
Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions?Theodoros Agorastos, Dimosthenis Miliaras, Alexandros F Lambropoulos, et al.
Molecular Human Reproduction|March 5, 2009
OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemnessSpyros I Papamichos, Vassiliki Kotoula, Basil C Tarlatzis, et al.
BMC Cancer|December 1, 2016
Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control studyEvangelia Pavlidou, Alexandros Daponte, Raquel Egea, et al.
Virology Journal|July 25, 2019
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytologyAleksandra Pesic, Amrei Krings, Matthias Hempel, et al.
Plos One|March 21, 2015
Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytologyTheodoros Agorastos, Kimon Chatzistamatiou, Taxiarchis Katsamagkas, et al.
Gynecologic Oncology|July 2, 2021
Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samplesKimon Chatzistamatiou, Athena Tsertanidou, Theodoros Moysiadis, et al.
Frontiers in Microbiology|December 15, 2023
High risk HPV-positive women cervicovaginal microbial profiles in a Greek cohort: a retrospective analysis of the GRECOSELF studyElectra Sofou, Glykeria Gkoliou, Nikolaos Pechlivanis, et al.
Pageof 6